Aiswarya | Spectroscopy | Best Scholar Award

Dr. Aiswarya | Spectroscopy | Best Scholar Award 

Research scholar at Sri Manakula Vinayagar Engineering college, India

P. Aiswarya is a dedicated research scholar at Sri Manakula Vinayagar Engineering College, Puducherry, specializing in spectroscopy, density functional theory, and molecular docking studies. Her academic journey reflects a strong passion for exploring bioactive organic molecules with therapeutic potential. She has conducted significant research on antifungal, antiviral, and antiparasitic compounds, with promising outcomes in drug discovery. Alongside research, she has contributed to teaching and guiding students, sharing her expertise in computational and experimental studies. Aiswarya’s commitment extends to scholarly service as a reviewer for reputed journals, highlighting her active involvement in advancing scientific communication. She has developed a niche in computational drug design and continues to explore molecules targeting infectious and neurological diseases. Her perseverance, analytical skills, and contributions in interdisciplinary research mark her as an emerging scientist devoted to innovation in biomedical sciences. With a strong foundation, she aims to expand her research impact globally in disease therapeutics.

Professional Profile

Orcid Profile | Scopus Profile

Education

P. Aiswarya has pursued her academic path with a deep interest in life sciences and pharmaceutical research, building expertise in spectroscopy, density functional theory, and molecular docking methodologies. Her educational background has equipped her with strong skills in computational modeling, analytical techniques, and drug discovery studies. She has focused her learning on exploring the structural and chemical behavior of bioactive molecules, contributing to her specialization in identifying potential therapeutic agents. Throughout her academic journey, she has been involved in projects that integrate theoretical and practical approaches to understanding complex biological processes. Her training has enabled her to handle multidisciplinary research involving organic chemistry, pharmacology, and computational biology. She has also contributed to guiding students in research-related tasks, strengthening her academic foundation. Her educational growth demonstrates a steady progression toward excellence in biomedical research and highlights her ability to bridge fundamental science with applied research for medical advancements.

Experience

P. Aiswarya’s professional journey is rooted in full-time research and academic engagement. She has worked extensively on projects dealing with the discovery of bioactive molecules and their therapeutic applications. Her completed research includes studies on alpha-cyano-4-hydroxycinnamic acid, which displayed antifungal and antiviral activity, and 4-amino-2-methoxybenzoic acid, which demonstrated antiparasitic potential. In addition to her independent research, she has contributed to teaching activities and guiding fellow researchers, fostering an academic environment of knowledge sharing. She has reviewed articles for international journals, contributing to the critical evaluation of scientific publications. Her experience spans molecular docking, computational drug design, and spectroscopy-based investigations, where she has gained a strong understanding of disease-related biomolecular interactions. She actively engages in collaborations with faculty and peers, focusing on advancing drug discovery research. Through her experience, she has built a balance between laboratory studies, theoretical research, and scientific communication, positioning herself as a promising scholar.

Research Focus

The central theme of P. Aiswarya’s research lies in the exploration of bioactive organic molecules with therapeutic potential. Her work integrates spectroscopy, density functional theory, and molecular docking studies to evaluate the structural and biological properties of compounds. She has focused on molecules with antifungal, antiviral, antiparasitic, and neuroprotective activities, offering promising leads for drug development. Notably, her completed projects highlighted the potential of alpha-cyano-4-hydroxycinnamic acid as an antifungal and antiviral agent, as well as 4-amino-2-methoxybenzoic acid as an antiparasitic candidate. Her ongoing research includes investigating molecules for neurodegenerative disorders and antileishmanial activity. By combining computational models with experimental validation, she contributes to rational drug design and molecular innovation. Her research direction emphasizes addressing global health challenges by discovering novel therapeutic strategies. With a clear vision of integrating interdisciplinary approaches, her focus is on bridging chemistry, biology, and pharmacology to support advances in disease treatment.

Publication Top Notes

Title: Comprehensive insights into 4-amino-2-methoxybenzoic acid: Spectral analysis, solvent impact, pharmacokinetic characteristics, and docking affinity investigation against Chagas disease

Journal: Journal of Molecular Structure (Published: 2025-01-12)

Summary:
This study investigates the structural, spectral, and pharmacokinetic properties of 4-amino-2-methoxybenzoic acid using a combination of computational and experimental techniques. Detailed FT-IR, FT-Raman, NMR, and UV-Visible spectral analyses were performed to understand the vibrational and electronic characteristics of the molecule. The influence of solvents on molecular stability and reactivity was explored to highlight environmental effects. Pharmacokinetic parameters, including absorption, distribution, metabolism, and excretion (ADME), were evaluated to predict drug-likeness and therapeutic potential. Furthermore, molecular docking studies revealed significant binding affinity of the compound against key target proteins associated with Trypanosoma cruzi, the causative agent of Chagas disease. The findings demonstrate the compound’s potential as a candidate for drug development, combining structural stability, favorable ADME properties, and promising docking interactions.

Conclusion

P. Aiswarya’s academic and research journey reflects her dedication to contributing meaningfully to biomedical sciences. Through her expertise in spectroscopy, density functional theory, and molecular docking, she has made notable progress in identifying bioactive molecules with significant therapeutic potential. Her contributions extend beyond laboratory research into teaching, mentoring, and peer review, showcasing her multifaceted role in academia. Her recognition through awards and her involvement in editorial responsibilities emphasize her commitment to advancing high-quality scientific knowledge. By focusing on molecules with antiviral, antifungal, antiparasitic, and neuroprotective properties, she addresses some of the most pressing global health challenges. Her work aligns with the broader vision of developing innovative drugs and therapeutic strategies. With determination, she continues to build her reputation as a promising scholar, striving to bridge fundamental research with applied medicine. Her future endeavors hold strong potential to expand the scope of drug discovery and contribute to global healthcare solutions.